Palette Life Sciences provides a wide range of products to improve the quality of life for the patients it serves.
Palette Life Sciences is a fully integrated life sciences company. Palette Life Sciences’ products improve patient outcomes in urology and urogynecology disorders, colorectal conditions, radiotherapy, and interventional oncology procedures. The company’s portfolio of available products includes Deflux®, Barrigel®, Solesta®, and Lidbree™. Palette Life Sciences moves rapidly to leverage novel applications of existing technologies to create breakthrough medical solutions. This focus enables the company to serve those often overlooked by traditional medical companies and improve patient quality of life.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 28, 2021 | Debt Financing | $40M | 1 | Silicon Valley Bank UK | — | Detail |
Oct 20, 2021 | Series Unknown | $30M | 1 | Melker Schörling | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Silicon Valley Bank UK | Yes | Debt Financing |
Melker Schörling | Yes | Series Unknown |